Human apoE ELISA development kit (HRP), Human
[CAT#: NK1120FY022]
- Applications:
- ELISA
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Species Reactivity
Human
Applications
ELISA
Relevant Diseases
Alzheimer's Disease
Research Areas
Neurodegeneration
Assay Type
ELISA Kits
Linear Range
0.1-10 ng/ml
Components
Capture mAb (E276)
Biotinylated detection mAb (E887)
Streptavidin-HRP
Recombinant human apoE ELISA standard
Biotinylated detection mAb (E887)
Streptavidin-HRP
Recombinant human apoE ELISA standard
Research Use Only
For research use only
1. Bankwitz, D., et al. (2014). Role of Hypervariable Region 1 for the Interplay of Hepatitis C Virus with Entry Factors and Lipoproteins. Journal of virology.
2. Bissig-Choisat, B., et al. (2015). Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nature Communications.
3. Handattu, S. P., et al. (2013). Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. Atherosclerosis.
4. Liu, M., et al. (2012). Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. American journal of physiology. Regulatory, integrative and comparative physiology.
5. van Harten, A. C., et al. (2017). CSF ApoE predicts clinical progression in nondemented APOEepsilon4 carriers. Neurobiology of aging.
2. Bissig-Choisat, B., et al. (2015). Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nature Communications.
3. Handattu, S. P., et al. (2013). Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. Atherosclerosis.
4. Liu, M., et al. (2012). Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. American journal of physiology. Regulatory, integrative and comparative physiology.
5. van Harten, A. C., et al. (2017). CSF ApoE predicts clinical progression in nondemented APOEepsilon4 carriers. Neurobiology of aging.
Neural Genes
Kits
Neural Proteins & Peptides
Neural Antibodies
Neural Cell Lines
For Research Use Only. Not For Clinical Use.
